Afinion sales gather momentum, but marketing costs hit Axis-Shield profits
This article was originally published in Clinica
Executive Summary
Anglo-Norwegian diagnostics company Axis-Shield saw a drop in pre-tax profits for the first half of 2007, as the cost of scaling up the production of, and commercialising, its new-generation Afinion analyser upped operating expenses, and unfavourable foreign exchange rates weighed down on revenues.